Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pomalidomide for Myelofibrosis Patients

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Celgene
Information provided by (Responsible Party):
M.D. Anderson Cancer Center
ClinicalTrials.gov Identifier:
NCT00946270
First received: July 23, 2009
Last updated: November 14, 2016
Last verified: November 2016